UHT logo

UNIVERSAL HEALTH RLTY INCOME

UHTNYSE
πŸ† #2277 by market capEarnings Oct 26US Equity
$40.75β–Ό $0.65 (βˆ’1.59%)
πŸŒ™ After hours$40.75β–² 0.00%Regular close Β· extended-hours price shown
1hβ€”
24hβ–Ό 1.6%
7dβ–Ό 3.7%
14dβ–Ό 9.0%
30dβ–Ό 5.6%
1yβ–² 3.0%
🏦Market Cap
$566M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+0.8%
Slowing
πŸ“ŠGross Margin
70.2%
High
πŸ’΅FCF Margin
38.2%
Strong
βš–οΈP/S Ratio
5.8x
Fair
Otter Score
55
Weak

Trading Snapshot

Day Range
$40.17 – $40.92
52-Week Range
$35.26 – $46.30
Volume
$2.70B
Avg Volume
$2.00B
Shares Outstanding
13.9M
Next Earnings
Oct 2, 2026

Fundamentals Snapshot

Annual Revenue
$99M
Last Q Revenue
$25M
P/E Ratio
29.7
P/S Ratio
5.8x
EPS (TTM)
$1.39
Dividend Yield
7.19%

Why Investors Own UHT

  • βœ“High-growth profile β€” revenue up +6.6% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 70% gross margin and 14% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$99Mβ–² +2.8% YoY
Gross Margin (TTM)
70.1%β–² +3.2% YoY
Operating Income (TTM)
$26Mβ–² +2.8% YoY
Free Cash Flow (TTM)
$13Mβ–² +2.8% YoY

About UNIVERSAL HEALTH RLTY INCOME

Universal Health Realty Income Trust (UHT) operates as a real estate investment trust (REIT) dedicated to investing in properties within the healthcare and human services industries. Its portfolio is diverse, encompassing a range of facilities such as acute care hospitals, rehabilitation centers, sub-acute care facilities, medical office buildings, freestanding emergency departments, and childcare centers. The trust currently holds 71 properties across 20 U.S. states, two of which are actively under construction.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
55/100

Analyst Price Target

β“˜
Average Target
$50.36
β–² +23.6% Upside
High Target$62.20
Low Target$41.69
Based on 21 analysts

Latest News & Updates